Cite Filings / APUS
Feed Companies Filings Check
Sign in

CIK 0001894525

  • Emerging growth company

Apimeds Pharmaceuticals US, Inc.

Sign in to watch
Ticker
APUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851099700
Phone
+1 848-201-5010
Business address
100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
Filings Financials Insiders Search text
All 130 Financials 36 Executive Compensation 31 Insider Trading 38 Beneficial Ownership Interest 6 Business Combinations 31 Public Offerings 24 Others 23
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13D/A Stake Beneficial Ownership Report 2026-05-07
  3. SCHEDULE 13D/A Stake Beneficial Ownership Report 2026-03-30
  4. SCHEDULE 13D/A Stake Beneficial Ownership Report 2026-03-20
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-02-11
  6. SCHEDULE 13D/A Stake Beneficial Ownership Report 2026-01-26
  7. SCHEDULE 13D Stake ● Beneficial Ownership Report 2025-05-19

Page 1 of 1 · 6 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…